Dynamic Perfusion Assay Configuration Services
Translating a complex biological hypothesis into a robust, high-fidelity microphysiological system requires the culture conditions, the substrate, and the readout to be matched to the question being asked. Whether you are looking to mitigate compound absorption issues, optimize shear stress profiles, or scale up evaluations utilizing robust thermoplastics, ProNAMs is your full-cycle efficacy evaluation partner.
Core Technical Capabilities
Developing robust and predictive microphysiological systems (MPS) requires more than successfully culturing cells in a static vessel. It necessitates the precise control and extensive characterization of the biophysical, structural, and material environment. ProNAMs specializes in the configuration of next-generation MPS, bridging the gap between traditional in vitro cultures and complex human physiology.
To ensure the highest level of biological relevance and data reproducibility, our perfusion assay configuration process precisely controls and validates three critical dimensions of the micro-physiological environment.
Dynamic Microenvironment Characterization
A biologically relevant model relies on precise biophysical cues. We systematically optimize and document the technical parameters governing the dynamic cellular environment, including controlled flow profiles and physiologically relevant shear stress, as well as validated media formulations and precise perfusion rates to maintain nutrient gradients and sustain long-term cellular viability.
Scaffold and Extracellular Matrix Engineering
The structural foundation of an MPS directly impacts cellular behavior. We rigorously characterize the scaffolds and matrices used in the evaluation to minimize lot-to-lot variability and maximize tissue maturation, including complete documentation of architecture, mechanical properties, and substrate compatibility.
Material Integrity and Assay Fidelity
Accurate pharmacological profiling requires high confidence that the test article acts on the cells, not the consumable. We conduct rigorous baseline validations to rule out material-induced artifacts, including mitigation of compound absorption, comprehensive analytical assessments for material leaching, and interface biocompatibility validation.
Standardization for Reproducibility
By standardizing these critical characteristics, we actively control the factors that influence experimental variability, ensuring a highly reproducible, tissue-specific architecture across all data delivery workflows.
Substrate Material Selection for Assay Optimization
The performance of an MPS is dictated by the material properties of the underlying consumable. While polydimethylsiloxane (PDMS) is frequently utilized for rapid baseline modeling due to its biomimetic elasticity, engineering plastics are the preferred choice for commercial-grade drug screening services to avoid small-molecule absorption.
PDMS remains the core substrate for early-stage assay configuration and specific physiological simulations.
- Superior Gas Permeability: Allows excellent permeation of oxygen and carbon dioxide, fulfilling cellular respiration needs without complex external gas lines.
- Dynamic Biomechanical Simulation: Effectively replicates mechanical stress associated with organ movements, such as lung expansion, intestinal peristalsis, and heartbeats.
- High Optical Transparency: Excellent for real-time microscopic observation and high-content fluorescence imaging due to its low autofluorescence.
- Biocompatibility: Non-toxic and supports cell adhesion and growth.
- Established Device Formats: Available in a wide range of commercial device formats, supporting fast iteration during assay development.
Thermoplastics and Engineering Plastics (COC/COP, PC, PS)
For high-throughput screening and scalable evaluations, engineering plastics are becoming the new mainstream, overcoming the critical limitations of PDMS.
- No Drug Absorption: Unlike PDMS, plastics do not absorb hydrophobic small-molecule drugs, ensuring accurate drug concentration calculations for toxicology and efficacy screening.
- High-Throughput Assay Ready: Highly suitable for large-scale, reproducible evaluations utilizing industrial-grade injection-molded consumables.
Cyclic olefin copolymer/polymer (COC/COP) are the preferred choice for commercial MPS assays, offering glass-like transparency, exceptional chemical stability, and zero drug absorption. Polystyrene (PS) is standard for cell culture, while Polycarbonate (PC) is frequently used to create porous semi-permeable membranes that simulate barriers like the blood-brain or alveolar-capillary barriers.
Substrate choice is one of the first decisions we make with you, because it determines both the biomechanical realism of the model and the accuracy of your dose response data. The comparison below summarizes the trade-offs we work through in that decision.
Table 1. Comparison of Substrate Materials
| Feature | PDMS | COC / COP | PC | PS |
|---|---|---|---|---|
| Primary Use | Assay Development, Respiratory/Cardiac MPS | Drug Screening Services | Porous Membranes | Standard Cell Culture |
| Gas Permeability | Excellent: Ideal for cell respiration | Low: Requiring active perfusion | Moderate | Low |
| Drug Absorption | High: Absorbing hydrophobic molecules | Negligible: Ensuring accurate dosing | Low | Low |
| Optical Quality | Excellent (Low autofluorescence) | Superior (Glass-like clarity) | Good (Visible spectrum) | Excellent |
| Elasticity | High: Dynamic biomechanical simulation | Rigid: Structural stability | Rigid: Durable | Rigid |
| Scalability | Lab-scale configuration | Standardized high-throughput | High | High |
Computational Fluid Dynamics and Flow Optimization
We utilize computational fluid dynamics (CFD) and multi-physics simulations to optimize the biomimetic fidelity of every fluidic microenvironment. This quantitative approach ensures that micro-eddies, shear stress, and nutrient gradients are precisely controlled to promote healthy tissue growth and realistic physiological responses.
- Shear Stress Optimization: Precisely calculating the mechanical forces required to mimic blood flow in vascular MPS or interstitial flow in 3D TME models.
- Nutrient and Oxygen Perfusion: Simulating mass transfer to prevent necrotic cores in 3D tissue architectures.
- Real-Time Predictive Modeling: Analyzing how complex 3D geometries affect drug concentration and metabolite distribution.
By utilizing computer simulations, we comprehensively understand the physical and chemical processes of the fluidic system, optimize the dynamic perfusion layout, effectively enhance data reliability, and shorten the screening cycle.
Full-Cycle Configuration and Assay Development
ProNAMs provides a comprehensive roadmap for transforming a biological hypothesis into a functional, validated evaluation model. Our expertise extends to complex multi-tissue fluidic models and the integration of real-time biosensors for high-content analysis.
Our Technical Workflow
Concept and Feasibility
We define fluidic microenvironment requirements, including extracellular matrix architecture, biophysical cues, and organotypic cell layouts.
Simulation-Driven Configuration
Utilizing 3D kinetic modeling to analyze inlet flow rates, diffusion coefficients, and boundary conditions.
Feasibility Validation
Configuration on commercially available platforms, followed by functional validation of 3D barrier models.
Optimization and Performance Verification
Refinement of surface coatings and downstream process optimization for consistent data delivery.
Advanced Application Expertise
- Barrier MPS: Modeling complex interfaces like the blood-brain barrier (BBB) or intestinal epithelium using multi-layer dynamic perfusion platforms.
- Disease MPS: Specialized platforms for studying hepatitis, NASH, or 3D tumor microenvironments under dynamic flow.
- High-Throughput Screening (HTS): Optimized layouts for large-scale toxicity assessments and pharmacokinetic (PK) profiling.
Comprehensive Data Deliverables
Transparency and traceability are integral to our service. Upon study completion, we provide a highly detailed technical data package that accompanies your biological endpoints. Standard technical deliverables include:
- Fluidic Profiling Reports: Validated flow rates, shear stress calculations, and gradient modeling.
- Matrix Characterization Data: Rheological measurements, architectural imaging, and consumable specification with lot documentation.
- Material Validation Sets: Compound recovery/mass-balance data to verify target concentrations, alongside baseline cytotoxicity profiles of the blank platform.
Ready to Configure Your Dynamic Perfusion Assay?
Application-Specific Assay Development: Bring your cell layouts or physiological targets. We manage the CFD flow simulation, substrate selection, and biological validation workflow, and deliver high-content automated data.
Material and Assay Optimization: Evaluate the appropriate substrate, from biomimetic PDMS for dynamic biomechanical simulation to commercial-grade thermoplastics for high-throughput screening.
Schedule a Consultation